EAPA Litigation

Under the Enforce and Protect Act, CBP investigates whether a company is evading particular antidumping and countervailing duty orders. Litigation on determinations made under the relatively new statute have centered on due process protections for respondents, CBP's evidentiary basis for its decisions and the interplay of decisions made on the scope of the applicable AD/CVD orders from both CBP and the Commerce Department. The Court of Appeals for the Federal Circuit issued a key decision for all EAPA cases in Royal Brush Manufacturing v. United States, when it found CBP to have violated a respondent's due process protections by failing to provide it with access to the business proprietary information used in the proceeding.

Date Range:

Author:

Topic:

Refine Category Search

Clear Terms

Search Primer

Multi-word term: Place inside quotes to ensure an exact match together (e.g. "China import").

Term list: Separate terms with spaces, not commas or semicolons to find either word (e.g. AD/CVD antidumping).

Acronyms: Use all capital letters (e.g., ACE).

Required term: If a term must be included in any resulting articles, prefix it with a plus sign (e.g., CBP +releases).

Excluded term: If a term should be excluded from any articles being found, prefix it with a minus sign (e.g., -ruling).

Singular form: Use the singular form when doing multi-word terms (e.g. "russian export control" instead of "russian export controls").

Shortest word form: When you have different word forms in a quoted term, include the shortest version if it is the last part of the expression (e.g., "entity list" instead of "entity listing" or "entity listed").

New and Revised FDA Import Alerts for Feb. 11

February 12, 2013 by Brian Feito|FDA

On Feb. 11 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:

Other Modified FDA Import Alerts for the Week of Feb. 4-10

February 12, 2013 by Brian Feito|FDA

During the week of Feb. 4-10, the Food and Drug Administration modified the following existing Import Alerts (not otherwise listed on the FDA's new and revised import alerts page) on the detention without physical examination and/or surveillance of:

FDA Posts Online Training Module for Foreign Seafood Producers Selling Product in U.S.

February 12, 2013 by Brian Feito|FDA

The Food and Drug Administration posted an online training module for foreign aquaculture producers to help them comply with FDA seafood import regulations. The module is hosted by the Joint Institute for Food Safety and Applied Nutrition at the University of Maryland, which also provides certificates upon completion. The training course is designed to clarify how FDA regulates drugs for aquaculture, and provides information to help identify what drugs may be used and how they should be used to prevent unacceptable residues. The course also includes a section on the judicious use of antimicrobials. The module is available here.

New and Revised FDA Import Alerts for Feb. 8

February 11, 2013 by Brian Feito|FDA

On Feb. 8 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:

Importer Recalls Chinese Dried Mushrooms for Undeclared Allergen

February 11, 2013 by Brian Feito|FDA

DZH Import & Export Inc. of New York is recalling its “Curiosity Of Dashan” dried mushrooms imported from China because of undeclared sulfites that could provoke allergic reactions. The recalled mushrooms come in a 3.5oz containers, packed on a plastic tray with the following code: BEST BEFORE: MAY 3rd, 2013. The UPC code is 6939457003484. The product was sold in New York City.

New and Revised FDA Import Alerts for Feb. 7

February 8, 2013 by Brian Feito|FDA

On Feb. 7 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:

FDA and Xavier University to Hold Conference March 12-13 on Pharma Supply Chain

February 8, 2013 by Brian Feito|FDA

The Food and Drug Administration’s Cincinnati District, in conjunction with Xavier University, will hold the “PharmaLink 2013” conference on the global pharmaceutical supply chain March 12-14 in Cincinnati. Topics on the agenda include the impact of new legislation on the global supply chain, FDA policy and guidance, and the impact of contract manufacturing on drug shortages. Advance registration ends Feb. 18, but registration will be available after that date and onsite at increased rates. Registration and the conference agenda are available here.

New and Revised FDA Import Alerts for Feb. 6

February 7, 2013 by Brian Feito|FDA

On Feb. 6 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:

FDA Enforcement Report on Recalls & Field Corrections for Feb. 6

February 7, 2013 by Brian Feito|FDA

The Food and Drug Administration issued its weekly Enforcement Report for Feb. 6 that lists the status of recalls and field corrections for food, drugs, biologics, and devices. The report covers both domestic and foreign firms.

FDA Issues February Interstate Certified Shellfish Shippers List

February 7, 2013 by Brian Feito|FDA

The Food and Drug Administration issued the February Interstate Certified Shellfish Shippers List (ICSSL). The ICSSL is published monthly for the information and use by food control officers, the seafood industry and other interested persons. The shippers listed have been certified by regulatory authorities in the U.S., Canada, Chile, Korea, Mexico and New Zealand under the uniform sanitation requirements of the National Shellfish Program.